AIM ImmunoTECH Announces Possible Coronavirus Treatment, Shares Rockets
AIM ImmunoTech Inc (NYSEAMERICAN: AIM) indicated that it was testing its SARS treatment, Ampligen, as a possible treatment for COVID-19. AIM ImmunoTECH plans to carry the tests in Japan with trials supervised by the World Health Organisation’s Hideki Hasegawa.
According to the company, Ampligen could be an effective treatment of the new coronavirus because of its previous effectiveness in treating the SARS coronavirus. The company tested the drug with mice, whereby those they received the Ampligen treatment survived while those that didn’t receive died.
The SARS coronavirus and COVID-19 have similar makeup in that the regulatory RNA sequences in the new virus are identical to that of SARS-CoV-1; thus, the drug might be effective.
Thomas Equels, the CEO of the company, indicated that because of similarities between the viruses, Ampligen would be critical in developing a protective therapy for COVID-19. He added that they were delighted to work with Japan’s National Institute of Infectious Disease to address the pandemic.
CBD Unlimited targeting access to 20,000 stores in 2020
Another company that is catching headlines is CBD Unlimited Inc. (OTC: EDXC), with its CBD products manufactured from hemp extracts that contain THC levels of less than 0.3%. CBD Unlimited Inc. (OTC: EDXC) offers a wide variety of products ranging from capsules and tropicals to oils and pet products that help in treating anxiety, pain, and inflammation.
CBD Unlimited Inc. (OTC: EDXC) has been expanding its retail footprint in the US, and currently, the company has around 5,600 stores across the US, where customers can access their products. Last year, CBD Unlimited Inc. (OTC: EDXC) generated sales of around $1.49 million, representing a YoY growth of 101%.
In 2020 CBD Unlimited Inc. (OTC: EDXC) is targeting to tie up around 20,000 stores while in the long term CBD Unlimited has set its sights to gain access to over 50,000 stores. CBD Unlimited Inc. (OTC: EDXC) is also growing its international presence, and It can now sell its products in South Africa as well as Puerto Rico.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Stock Market Press
110 Wall St.
New York, NY 10005 firstname.lastname@example.org
Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press